Channel Medsystems Announces Publication of Long-term Clinical Outcomes with Cerene® Cryotherapy for the Treatment of Heavy Menstrual Bleeding
Cerene Cryotherapy is clinically proven to significantly reduce menstrual bleeding and premenstrual symptoms safely and effectively with high patient satisfaction through 36 months following treatment
BERKELEY, Calif.–(BUSINESS WIRE)–Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced the publication of long-term clinical outcomes from the CLARITY clinical study, evaluating the safety and effectiveness of Cerene® Cryotherapy for the treatment of heavy menstrual bleeding (HMB) in the International Journal of Women’s Health.
| “Findings from the CLARITY study should give physicians confidence in the long-term… |